Model Number PP6-530-0027-US |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Corneal Clouding/Hazing (1878); Blurred Vision (2137); Loss of Vision (2139); Visual Disturbances (2140)
|
Event Date 08/08/2017 |
Event Type
Injury
|
Manufacturer Narrative
|
Additional information has been requested to confirm that the device was explanted as planned and request that it be returned for evaluation.The device history record (dhr) review of the manufacturing lot was performed and there were no discrepancies or unusual findings related to the reported issue.Corneal haze is listed in the device labeling as a known potential risk.Complaint reference number: (b)(4).
|
|
Event Description
|
The subject was enrolled in the (b)(6) clinical trial and underwent implantation of the investigational corneal inlay in the left eye on (b)(6) 2013.Four years postoperatively, the patient presented with corneal haze and complained of poor near vision and headaches from eye strain.The patient was prescribed topical steroids, but requested inlay explantation (scheduled for (b)(6) 2017).Additional information has been requested.
|
|
Manufacturer Narrative
|
The explanted inlay was returned to the manufacturer and subjected to visual microscopic inspection and dimensional analysis.The edge thickness and diameter were measured and found to be within specifications.Scratches and debris were observed on the device, but these findings are consistent with findings for corneal inlays that have been explanted since surgical instruments are required to remove the device from the eye and place it in a hydrated storage container for transport.Decreased bcdva and visual symptoms are listed in the device labeling as known potential risks.(b)(4).
|
|
Event Description
|
Patient follow-up was requested from the surgeon, who provided the following additional information.Corneal haze is characterized as grade 1, central.The patient's best corrected distance visual acuity (bcdva) decreased from 20/20 (preoperatively) to 20/25 at onset of issue.Corneal haze resulted in visual disturbances such as blurred vision, ghost images, double vision and fluctuation of vision which caused frequent headaches to the patient.Headache is described as mild to moderate when trying to focus at near.The inlay was explanted on (b)(6) 2017.Non-compliance with the prescribed steroid regimen is suspected to be contributory to the reported issues.
|
|
Manufacturer Narrative
|
Complaint reference #: (b)(4).
|
|
Event Description
|
The investigator provided the following update on the study subject.At the one-month post-explant examination on (b)(6) 2017, bcdva was 20/25 and the patient reported experiencing moderate pain and aching.
|
|
Search Alerts/Recalls
|